According to FutureWise analysis the market for Obesity Treatment in 2023 is US$ 17.06 billion, and is expected to reach US$ 37.44 billion by 2031 at a CAGR of 10.30%.
A medical disease known as obesity is brought on by the body's fat cells expanding in size. This syndrome is linked to a number of health issues, such as diabetes, heart disease, high blood pressure, and several cancer types. Lack of sleep, inactivity, and excessive junk food intake are some of the key contributors to obesity. A healthy diet and regular exercise are thought to be the cornerstones of the treatment of obesity. It has been demonstrated that dietary modifications, increased physical activity, and behavioral adjustments can assist in improving the situation and stop several obesity-related health problems. Doctors may recommend specialized weight-loss methods and drugs in more severe situations. Orlistat (Xenical, Alli), naltrexone-bupropion (Contrave), phentermine-topiramate (Qsymia), semaglutide (Wegovy), and others are well-known FDA-approved weight-loss medications.
For both advanced nations and lower- and middle-income economies, obesity is a major problem. According to the World Health Organisation report, obesity and overweight are linked to several diseases and have a higher mortality rate than undernourishment. A significant prevalence of chronic disorders, such as hypertension, diabetes, and orthopedic conditions, is reported in the overweight and obese population. Teenagers' weight increase is also a result of their changing preferences for sedentary lives, physical inactivity, and altered eating habits. The rise in obesity is expected to propel the market expansion.
A medical condition known as obesity is characterized by the body's fat cells growing in size. This syndrome has links to diabetes, high blood pressure, cardiovascular disease, and several types of cancer. Several factors, such as insufficient sleep, inactivity, and an excessive intake of junk food, bring on obesity. Rates of obesity have increased recently due to factors like the rise of the "work from home" trend, inactivity, unhealthy eating habits, and risky behaviors. As the tendency towards working from home has grown, as has inactivity, poor eating habits, obesity rates have increased. The widespread use of pre-packaged, ready-to-eat meals, for example, has significantly affected a large portion of the population. In accordance with the Institute for Health Metrics and Evaluation, about 30% of individuals worldwide are overweight or obese. The market for obesity treatment is anticipated to grow over the forecast period due to the rising incidence of obesity and its associated disorders. Moreover, the prevalence of obesity has increased significantly, and pharmaceutical therapy now poses a considerable threat to health. Focused treatment with single-agent antibody medications may lead to quicker results with improved therapeutic efficacy, according to studies in this area. It is projected that ongoing clinical trials and drug development by different market participants will boost the target market's revenue growth. However, in developing countries, weight loss surgery costs are not properly covered. Clinical studies are also delayed due to safety issues with pharmaceuticals for managing obesity, and only a few therapies hit the market. Particular drug formulations can bring on drug-induced cancer or cardiovascular disease. For instance, the FDA had requested Eisai to remove its weight-loss drug Belviq from the market after studies showed that users had a greater chance of developing cancer. Such incidents are predicted to impede market expansion.
FutureWise Market Research has published a report that provides an insightful analysis of obesity treatment market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, the obesity treatment market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.